These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30783111)

  • 1. Defining a critical period in calvarial development for Hedgehog pathway antagonist-induced frontal bone dysplasia in mice.
    Jiang Y; Zhang S; Mao C; Lai Y; Wu D; Zhao H; Liao C; Chen W
    Int J Oral Sci; 2019 Feb; 11(1):3. PubMed ID: 30783111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hedgehog pathway antagonist-induced oromandibular limb hypogenesis in mouse].
    Jiang YJ; Mao CQ; Lai YZ; Weng YP; Zhang SX; Chen WH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Jan; 53(1):36-41. PubMed ID: 29972962
    [No Abstract]   [Full Text] [Related]  

  • 3. Hedgehog signaling mediates woven bone formation and vascularization during stress fracture healing.
    Kazmers NH; McKenzie JA; Shen TS; Long F; Silva MJ
    Bone; 2015 Dec; 81():524-532. PubMed ID: 26348666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous hedgehog antagonist delays but does not prevent fracture healing in young mice.
    Liu X; McKenzie JA; Maschhoff CW; Gardner MJ; Silva MJ
    Bone; 2017 Oct; 103():241-251. PubMed ID: 28734986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b.
    Karlou M; Lu JF; Wu G; Maity S; Tzelepi V; Navone NM; Hoang A; Logothetis CJ; Efstathiou E
    Prostate; 2012 Nov; 72(15):1638-47. PubMed ID: 22457212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis.
    Kumar V; Dong Y; Kumar V; Almawash S; Mahato RI
    Theranostics; 2019; 9(25):7537-7555. PubMed ID: 31695785
    [No Abstract]   [Full Text] [Related]  

  • 7. Definition of critical periods for Hedgehog pathway antagonist-induced holoprosencephaly, cleft lip, and cleft palate.
    Heyne GW; Melberg CG; Doroodchi P; Parins KF; Kietzman HW; Everson JL; Ansen-Wilson LJ; Lipinski RJ
    PLoS One; 2015; 10(3):e0120517. PubMed ID: 25793997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the critical period of hedgehog pathway inhibitor-induced cranial base dysplasia in mice.
    Chen J; Tang W; Lin C; Hong Y; Mao C; Lai Y; Liao C; Lin M; Chen W
    Dev Dyn; 2021 Apr; 250(4):527-541. PubMed ID: 33165989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hedgehog signalling attenuates UVB-induced skin photoageing.
    Kim W; Kim E; Yang HJ; Kwon T; Han S; Lee S; Youn H; Jung Y; Kang C; Youn B
    Exp Dermatol; 2015 Aug; 24(8):611-7. PubMed ID: 25939425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of Hedgehog Signaling by Vismodegib Leads to Cleft Palate and Delayed Osteogenesis in Experimental Design.
    Zhang S; Wang C; Xie C; Lai Y; Wu D; Gan G; Chen W
    J Craniofac Surg; 2017 Sep; 28(6):1607-1614. PubMed ID: 28863112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the hedgehog inhibitor GDC-0449, alone or in combination with dasatinib, on BCR-ABL-positive leukemia cells.
    Okabe S; Tauchi T; Tanaka Y; Katagiri S; Ohyashiki K
    Stem Cells Dev; 2012 Nov; 21(16):2939-48. PubMed ID: 22642671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vismodegib.
    Meiss F; Andrlová H; Zeiser R
    Recent Results Cancer Res; 2018; 211():125-139. PubMed ID: 30069764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.
    Scales SJ; de Sauvage FJ
    Trends Pharmacol Sci; 2009 Jun; 30(6):303-12. PubMed ID: 19443052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation.
    Wong H; Alicke B; West KA; Pacheco P; La H; Januario T; Yauch RL; de Sauvage FJ; Gould SE
    Clin Cancer Res; 2011 Jul; 17(14):4682-92. PubMed ID: 21610148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hedgehog signalling pathway in bone formation.
    Yang J; Andre P; Ye L; Yang YZ
    Int J Oral Sci; 2015 Jun; 7(2):73-9. PubMed ID: 26023726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with Hedgehog pathway inhibitors.
    Low JA; de Sauvage FJ
    J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel therapeutic approach against B-cell non-Hodgkin's lymphoma through co-inhibition of Hedgehog signaling pathway and autophagy.
    Fan J; Zeng X; Li Y; Wang S; Yang P; Cao Z; Wang Z; Song P; Mei X; Ju D
    Tumour Biol; 2016 Jun; 37(6):7305-14. PubMed ID: 26666826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis.
    Chen Q; Zhang H; Wu M; Wang Q; Luo L; Ma H; Zhang X; He S
    J Pharmacol Sci; 2018 Jul; 137(3):256-264. PubMed ID: 30064819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDC-0449-a potent inhibitor of the hedgehog pathway.
    Robarge KD; Brunton SA; Castanedo GM; Cui Y; Dina MS; Goldsmith R; Gould SE; Guichert O; Gunzner JL; Halladay J; Jia W; Khojasteh C; Koehler MF; Kotkow K; La H; Lalonde RL; Lau K; Lee L; Marshall D; Marsters JC; Murray LJ; Qian C; Rubin LL; Salphati L; Stanley MS; Stibbard JH; Sutherlin DP; Ubhayaker S; Wang S; Wong S; Xie M
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5576-81. PubMed ID: 19716296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins repress hedgehog signaling in medulloblastoma with no bone toxicities.
    Fan Q; Gong T; Zheng C; Ng JMY; Chen J; Myers C; Hensley H; Curran T; Yang ZJ
    Oncogene; 2021 Mar; 40(12):2258-2272. PubMed ID: 33649536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.